Clinical feature	Statistical test	Significant genes	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
Time to Death	Cox regression test	N=16	shorter survival	N=6	longer survival	N=10
AGE	Spearman correlation test	N=1577	older	N=426	younger	N=1151
NEOPLASM DISEASESTAGE	Kruskal-Wallis test	N=148	 	 	 	 
PATHOLOGY T STAGE	Spearman correlation test	N=123	higher stage	N=30	lower stage	N=93
PATHOLOGY N STAGE	Spearman correlation test	N=56	higher stage	N=46	lower stage	N=10
PATHOLOGY M STAGE	Kruskal-Wallis test	N=1207	 	 	 	 
GENDER	Wilcoxon test	N=5	male	N=5	female	N=0
HISTOLOGICAL TYPE	Kruskal-Wallis test	N=6528	 	 	 	 
RADIATIONS RADIATION REGIMENINDICATION	Wilcoxon test	N=923	yes	N=923	no	N=0
NUMBER OF LYMPH NODES	Spearman correlation test	N=40	higher number.of.lymph.nodes	N=34	lower number.of.lymph.nodes	N=6
RACE	Kruskal-Wallis test	N=5204	 	 	 	 
ETHNICITY	Wilcoxon test	N=0	 	 	 	 
